Codagenix

Codagenix

A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.

All edits

Edits on 10 April, 2020
Jason D. Rowley
Jason D. Rowley edited on 10 April, 2020 2:39 pm
Edits made to:
Infobox (+1 properties)

Infobox

Industry
Edits on 7 April, 2020
Jessica Karpinski
Jessica Karpinski edited on 7 April, 2020 10:12 pm
Edits made to:
Infobox (+3 properties)
Description (+111/-57 characters)
Article (+327/-76 characters)
Further reading (+1 rows) (+5 cells) (+383 characters)
Categories (+2 topics)
Topic thumbnail

Codagenix

Biotechnology company developing live attenuated vaccines

A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.

Article

Company

Codagenix is a privately held, biotechnology company based in Stony Brook, New York. The company focuses on constructing live-attenuated viral vaccines against multiple targets using the company's proprietary technology platform, SAVE. Standing for Synthetic Attenuated Virus Engineering, the platform relies on synthetic biology and the rational 're-design' of a target virus' entire genomegenome to yield a vaccine strain. The customization process uses software-based algorithms to 're-code' the genome of a target virus.

The company's product pipeline includes vaccines for influenzainfluenza, respiratory syncytial virusrespiratory syncytial virus (RSV), denguedengue, foot and mouth disease virusfoot and mouth disease virus (FMDV), pathogenic E. Coli, and other targets.

COVID-19

In February 2020, the company teamed up with the Serum Institute of India to co-develop a live-attenuated vaccine for COVID-19. The company uses viral deoptimization technology in order to create multiple vaccine candidates for a virus.

Further reading

Title
Author
Link
Type
Date

Codagenix and Serum Institute of India Initiate Co-Development of a Scalable, Live-Attenuated Vaccine Against the 2019 Novel Coronavirus, COVID-19

Web

February 13, 2020

Infobox

Email address
admin@codagenix.com
Founded date
2012
Full address
3 Bioscience Park Drive | Farmingdale, NY 11735-0176

Categories

Edits on 9 July, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 July, 2019 2:49 pm
Edits made to:
Infobox (+1 properties)
Edits on 5 March, 2019
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 5 March, 2019 2:47 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 22 February, 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 22 February, 2019 8:14 pm
Edits made to:
Article (+21/-21 characters)

Article

Codagenix is a privately held, biotechnology company based in Stony Brook, New YorkStony Brook, New York. The company focuses on constructing live-attenuated viral vaccines against multiple targets using the company's proprietary technology platform, SAVE. Standing for Synthetic Attenuated Virus Engineering, the platform relies on synthetic biology and the rational 're-design' of a target virus' entire genome to yield a vaccine strain. The customization process uses software-based algorithms to 're-code' the genome of a target virus.

Edits on 14 February, 2019
Rebecca Hammond
Rebecca Hammond approved a suggestion from Golden's AI on 14 February, 2019 2:42 pm
Edits made to:
Infobox (+3 properties)
People (+1 rows) (+2 cells) (+19 characters)

People

Name
Role
Related Golden topics

Rishab Kaul

Employee

Infobox

Edits on 12 February, 2019
Sameeha Sulaiman
Sameeha Sulaiman edited on 12 February, 2019 1:05 pm
Edits made to:
Further reading (-3 rows) (-8 cells) (-603 characters)

Further reading

Title
Author
Link
Type

Codagenix A Tiny Start-Up Ready To Take On The Goliaths Of The Vaccine Industry

Web

Codagenix Inc. Receives Phase I SBIR Grant from US Department of Agriculture to Develop Swine Influenza Vaccine

RSV vaccine player Codagenix snags $3M in public and private investment | FiercePharma

Web

Sameeha Sulaiman
Sameeha Sulaiman edited on 12 February, 2019 1:05 pm
Edits made to:
Infobox (+4 properties)
Article (+701 characters)
Further reading (+4 rows) (+11 cells) (+782 characters)

Article

Codagenix is a privately held, biotechnology company based in Stony Brook, New York. The company focuses on constructing live-attenuated viral vaccines against multiple targets using the company's proprietary technology platform, SAVE. Standing for Synthetic Attenuated Virus Engineering, the platform relies on synthetic biology and the rational 're-design' of a target virus' entire genome to yield a vaccine strain. The customization process uses software-based algorithms to 're-code' the genome of a target virus.

The company's product pipeline includes vaccines for influenza, respiratory syncytial virus (RSV), dengue, foot and mouth disease virus (FMDV), pathogenic E. Coli, and other targets.

Further reading

Title
Author
Link
Type

Codagenix A Tiny Start-Up Ready To Take On The Goliaths Of The Vaccine Industry

Web

Codagenix Inc. Receives Phase I SBIR Grant from US Department of Agriculture to Develop Swine Influenza Vaccine

RSV vaccine player Codagenix snags $3M in public and private investment | FiercePharma

Web

Xconomy: With $2M, Codagenix Becomes Accelerate LI's First VC-Backed Grad

Web

Infobox

Edits on 4 January, 2019
Sameeha Sulaiman
Sameeha Sulaiman edited on 4 January, 2019 3:28 pm
Edits made to:
Description (+57 characters)
People (+3 rows) (+6 cells) (+149 characters)
Topic thumbnail

Codagenix

Biotechnology company developing live attenuated vaccines

People

Name
Role
Related Golden topics

Eckard Wimmer

Co-Founder, Senior Scientific Officer

J. Robert Coleman

Co-Founder & COO

Steffen Mueller

Co-Founder, President, and Chief Scientific Officer

Edits on 21 April, 2018
Melanie Manipula
Melanie Manipula edited on 21 April, 2018 9:30 pm
Edits made to:
Topic thumbnail

Codagenix

A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.

Melanie Manipula"Initial topic creation"
Melanie Manipula created this topic on 21 April, 2018 9:03 pm
Edits made to:
Description
Academic papers
People
Further reading
Documentaries, videos and podcasts
Companies
Products
Topic thumbnail

 Codagenix

A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.